GT200000010A - Derivados de pirazolbencilamina sustituidos. - Google Patents

Derivados de pirazolbencilamina sustituidos.

Info

Publication number
GT200000010A
GT200000010A GT200000010A GT200000010A GT200000010A GT 200000010 A GT200000010 A GT 200000010A GT 200000010 A GT200000010 A GT 200000010A GT 200000010 A GT200000010 A GT 200000010A GT 200000010 A GT200000010 A GT 200000010A
Authority
GT
Guatemala
Prior art keywords
pirazolbencilamine
derivatives
substituted
letters
invention refers
Prior art date
Application number
GT200000010A
Other languages
English (en)
Inventor
Juergen Stolefuss
Gabriele Braueunlich
Berthold Hinzen
Thomas Kraemer
Josef Pernerstorfer
Thomas Studemann
Ulrich Nielsch
Martin Bechem
Emanuel Lohrmann
Christoph Gerdes
Michael Sperzel
Klemens Lustig
Lorenz Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000010A publication Critical patent/GT200000010A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE PIRAZOLBENCILAMINA SUSTITUIDOS DE FORMULA GENERAL(I) [EN LA QUE LAS LETRAS "A,D,E & G" REPRESENTAN GRUPOS SUSTITUYENTES POSIBLES IGUALES O DISTINTOS A HIDROGENO, HIDROXILO, HALOGENO, TRIFLUOROMETILO, ALQUILO O ALCOXI. Y LAS LETRAS "R´S" DISTINTOS GRUPOS FUNCIONALES CUYOS NOMBRES PUEDEN OBTENERSE DEL DOCUMENTO ORIGINAL], LA INVENCION SE REFIERE TANTO A LOS ENANTIOMEROS COMO A LOS DIASTEROISOMEROS Y A SUS CORRESPONDIENTES MEZCLAS, A PROCEDIMIENTOS PARA SU OBTENCION Y A SU USO COMO MEDICAMENTOS, ESPECIALMENTE PARA EL TRATAMIENTO Y PROFILAXIS DE ANEMIAS
GT200000010A 1999-02-04 2000-02-03 Derivados de pirazolbencilamina sustituidos. GT200000010A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19904396A DE19904396A1 (de) 1999-02-04 1999-02-04 Substituierte Pyrazolbenzylamin-Derivate

Publications (1)

Publication Number Publication Date
GT200000010A true GT200000010A (es) 2001-07-27

Family

ID=7896338

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000010A GT200000010A (es) 1999-02-04 2000-02-03 Derivados de pirazolbencilamina sustituidos.

Country Status (4)

Country Link
AU (1) AU2666200A (es)
DE (1) DE19904396A1 (es)
GT (1) GT200000010A (es)
WO (1) WO2000046206A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19904397A1 (de) * 1999-02-04 2000-08-10 Bayer Ag Verwendung von Pyrazol-Carbonsäureamiden
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
PE20120003A1 (es) 2009-01-30 2012-02-12 Glaxosmithkline Llc Hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil)etil}-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2-tiofenocarboxamida cristalino

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
DE69315836T2 (de) * 1992-06-10 1998-04-09 Fujisawa Pharmaceutical Co Pyrazolpyridine für die behandlung der anämie
ES2210374T3 (es) * 1995-06-07 2004-07-01 Ortho Pharmaceutical Corporation Compuestos y peptidos que se unen al receptor de eritropoyetina.
WO1997019039A1 (en) * 1995-11-17 1997-05-29 Novartis Ag Solid phase synthesis of heterocyclic compounds and combinatorial compound library

Also Published As

Publication number Publication date
DE19904396A1 (de) 2000-08-10
AU2666200A (en) 2000-08-25
WO2000046206A1 (de) 2000-08-10

Similar Documents

Publication Publication Date Title
GT199900217A (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios.
SV1997000009A (es) Nuevas oxazolidinonas sustituidas ref. lea 31534-sv
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CR9375A (es) Derivados de ciclopropanocarboxamida
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
GT200500375A (es) Derivados de piperidina y su uso como agentes antiinflamatorios
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
BRPI0413022A (pt) derivados de 3-amino cromado e 2-amino tetralina
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
AR028948A1 (es) Compuestos novedosos
GT200000011A (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevos materiales.
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
ECSP055567A (es) Derivados de indolinona sustituidos en posición 6, su preparación y su uso como medicamentos
GT199900154A (es) Agentes farmaceuticos para el tratamiento de la enfermedad de parkinson, adhd y microadenomas.
GT200000001A (es) Derivados de eter propargilico novedosos.
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
SV2002000041A (es) Derivados de resorcinol ref. pc10529/82897/bb
AR025796A1 (es) Quinazolinonas
GT200000010A (es) Derivados de pirazolbencilamina sustituidos.